We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Widecells Group Plc | LSE:WDC | London | Ordinary Share | GB00BD060S65 | ORD GBP0.0025 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.285 | 0.28 | 0.29 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMWDC
RNS Number : 5098H
WideCells Group PLC
15 November 2018
15 November 2018
WideCells Group PLC ('WideCells Group' or 'the Group')
Results of General Meeting
WideCells Group PLC, the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, is pleased to announce that all resolutions put to the Group's General Meeting held earlier today were duly passed on a show of hands.
The company had received proxy votes lodged in advance of the meeting showing over 98% of votes cast in favour of the resolutions.
**ENDS**
For further information, please visit the Company's website www.widecellsgroup.com, follow us on Twitter @WideCells_Group or contact:
WideCells Group CEO - João Andrade Tel: +351 919 033 171 Shard Capital Partners Broker - Damon Heath & Erik Tel: +44 (0) 20 7186 LLP Woolgar 9950 ---------------------------- --------------------- St Brides Partners PR - Priit Piip & Isabel de Tel: +44 (0) 20 7236 Limited Salis 1177 ---------------------------- ---------------------
Notes to Editors
WideCells Group PLC
WideCells Group PLC is building an integrated stem cell services company, focused on making stem cell treatments both accessible and affordable. This is delivered through three divisions:
-- CellPlan: the world's first stem cell healthcare insurance plan with financial cover for medical treatment, travel and accommodation expenses and concierge service to manage the treatment process.
-- WideCells: The Institute of Stem Cell Technology has been established and is based in the University of Manchester Innovation Centre to focus on stem cell research and regenerative medicine. WideCells also has international cryogenics divisions specialising in stem cell storage.
-- Wideacademy: developing an education and training division to promote awareness of the benefits of stem cell storage across the global general practice community.
Stem Cell Fast Facts:
-- Cord blood (which is taken from the umbilical cord) provides the most effective source of stem cells for families, because it is simple, safe and painless to collect, relative to other sources of stem cells such as bone marrow - WideCells will focus on promoting the collection and storage of cord blood.
-- Since 2005, there has been a 300% increase in the number of illnesses that can be treated using stem cells.
-- 82 illnesses can currently be treated using stem cell procedures.
-- Despite initial collection and storage often costing no more than a few GBPthousands, actual treatment can cost in the GBPhundreds of thousands - before the development of an insurance product such as CellPlan, the treatment remained largely available only to Higher Net Worth individuals.
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR).
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ROMBABTTMBABBAP
(END) Dow Jones Newswires
November 15, 2018 08:03 ET (13:03 GMT)
1 Year Widecells Chart |
1 Month Widecells Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions